Drug Description in Trials / DrugBank / KEGG DRUG

Search results

No.

Drug (Description in trials)

DrugBank

KEGG DRUG

KEGG GENES

KEGG PATHWAY

Disease ID

1

[1] Doxorubicin (Doxorubicin)

[1] Doxorubicin (Doxorubicin) 💬

[2] TOP2A,
TOP2B 💬

[1] Platinum drug resistance 💬

[5] 26, 28, 34, 65, 331 💬

2

Doxorubicin Hydrochloride

[1] Doxorubicin (Doxorubicin)

[1] Doxorubicin (Doxorubicin) 💬

[2] TOP2A,
TOP2B 💬

[1] Platinum drug resistance 💬

[3] 26, 34, 331 💬

3

Doxorubicin, methotrexate, cyclophosphamide, L-asparaginase

[4] Asparaginase Escherichia coli,
Cyclophosphamide,
Doxorubicin (Doxorubicin),
Methotrexate

[4] Methotrexate ,
Cyclophosphamide ,
Doxorubicin (Doxorubicin),
Cyclophosphamide 💬

Name	Other Names
Methotrexate	Methotrexate (JP18/USP/INN) Otrexup (TN) Xatmep (TN) REDITREX
Cyclophosphamide	Cyclophosphamide (USP) Cyclophosphamide hydrate (JP18) Cytoxan (TN) Neosar (TN)
Doxorubicin	Doxorubicin (USAN/INN) ADR Adriblastina (TN)
Cyclophosphamide	Cyclophosphamide (INN) Cyclophosphamide (TN) Cytoxan (TN)

[4] DHFR,
DHFR2,
TOP2A,
TOP2B 💬

[6] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate, Platinum drug resistance 💬

[1] 65 💬

4

Liposomal Doxorubicin

[1] Doxorubicin (Doxorubicin)

[1] Doxorubicin (Doxorubicin) 💬

[2] TOP2A,
TOP2B 💬

[1] Platinum drug resistance 💬

[1] 331 💬